Department of Cardiology, Heart Lung Center, Leiden University Medical Center, Leiden, The Netherlands.
Department of Cardiology, Heart Lung Center, Leiden University Medical Center, Leiden, The Netherlands; Department of Cardiology, Jessa Hospital, Hasselt, Belgium.
Am J Cardiol. 2022 Dec 1;184:63-71. doi: 10.1016/j.amjcard.2022.08.035. Epub 2022 Sep 23.
Worsening heart failure (HF), defined as hospitalization for worsening signs and symptoms of HF or the need for urgent intravenous diuretics, is often considered a surrogate of poor prognosis in clinical trials. However, data on the prognostic implications of worsening HF in patients with HF and reduced ejection fraction is limited. Patients who had a first echocardiographic diagnosis of left ventricular systolic dysfunction, defined as left ventricular ejection fraction (LVEF) ≤45%, were identified. Worsening HF was defined as hospitalization for HF or urgent need for intravenous diuretics. All-cause mortality was chosen as the study end point. A total of 1,801 patients (mean age 64 ± 12 years, 74% men) were analyzed. Worsening HF was observed in 275 patients (15%) during a median follow-up of 20 months, while, 435 patients (24%) died during a median follow-up of 60 months (Interquartile range 28 to 60 months). The 5-year survival rate was significantly lower in the worsening HF cohort compared with the non-worsening HF cohort (Log-rank p <0.0001), and it was significantly different between the worsening HF cohort and the nonworsening HF cohort for LVEF ≤25% (log-rank p <0.0001) and LVEF 26% to 34% (log-rank p = 0.038) but not for LVEF 35% to 45% (log-rank p = 0.14). After adjustment for important clinical and echocardiographic predictors, worsening HF was independently associated with a higher risk of all-cause mortality (hazard ratio 1.46, 95% confidence interval 1.09 to 1.96, p = 0.011). In conclusion, worsening HF, defined by HF hospitalization or the urgent need for intravenous diuretics, is independently associated with poor long-term prognosis in patients with HF and reduced ejection fraction.
恶化的心力衰竭(HF),定义为因 HF 恶化的体征和症状而住院或需要紧急静脉利尿剂治疗,通常被认为是临床试验中预后不良的替代指标。然而,HF 射血分数降低患者中恶化 HF 的预后意义的数据有限。确定了首次超声心动图诊断为左心室收缩功能障碍的患者,定义为左心室射血分数(LVEF)≤45%。恶化 HF 定义为因 HF 住院或需要紧急静脉利尿剂治疗。选择全因死亡率作为研究终点。共分析了 1801 例患者(平均年龄 64±12 岁,74%为男性)。在中位随访 20 个月期间,275 例(15%)患者出现恶化 HF,而在中位随访 60 个月期间(28 至 60 个月)435 例(24%)患者死亡。与非恶化 HF 组相比,恶化 HF 组的 5 年生存率显著降低(对数秩检验,p<0.0001),且与非恶化 HF 组相比,LVEF≤25%(对数秩检验,p<0.0001)和 LVEF 26%至 34%(对数秩检验,p=0.038)组的差异有统计学意义,但 LVEF 35%至 45%组(对数秩检验,p=0.14)差异无统计学意义。在调整重要的临床和超声心动图预测因素后,恶化 HF 与全因死亡率升高独立相关(风险比 1.46,95%置信区间 1.09 至 1.96,p=0.011)。总之,HF 住院或需要紧急静脉利尿剂治疗定义的恶化 HF 与 HF 射血分数降低患者的长期预后不良独立相关。